1400 16th Street
San Francisco, CA 94103
415 374 7782
Full-time employees: 1,700
|Dr. Randal W. Scott Ph.D.||Co-Founder & Chairman||50k||N/A||1958|
|Mr. Kenneth D. Knight||Pres, CEO & Director||1.4M||N/A||1961|
|Ms. Yafei Wen||Chief Financial Officer||1.4M||N/A||1973|
|Mr. Thomas R. Brida||Gen. Counsel, Chief Compliance Officer & Sec.||776.72k||N/A||1971|
|Ms. Hoki Luk||Head of Investor Relations and Capital Markets||N/A||N/A||1976|
|Mr. Lee Bendekgey J.D.||Chief Policy Officer||N/A||N/A||1958|
|Ms. Shelly D. Guyer||Chief Sustainability Officer||N/A||N/A||1960|
|Ms. Desarie French||Chief Talent Officer||N/A||N/A||N/A|
|Dr. W. Michael Korn M.D.||Chief Medical Officer||N/A||N/A||N/A|
|Mr. Jackson J. Finks C.F.A., CFA||Director of Investor Relations & Strategic Fin.||N/A||N/A||N/A|
Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
Invitae Corporation’s ISS governance QualityScore as of 1 May 2023 is 6. The pillar scores are Audit: 7; Board: 7; Shareholder rights: 6; Compensation: 6.